Literatuur
- 1.Singh S, et. al. Glucagonlike Peptide 1-based therapies and risk of hospitalisation for acute pancreatitis in Type 2 Diabetes Mellitus. JAMA Int Med. Published online February 25, 2013.
- 2.Gale EA. GLP-1 based agents and acute pancreatitis. Drugs safety falls victim to the three monkey paradigm. Brit Med J 2013;346:f1263.
- 3.US Food and Drug Administration. Incretin mimetic drugs for type 2 diabetes: early communication - Reports of ossible increased risk of pancreatitis and pre-cancerous findings of the pancreas.http://www.fda.gov; 03/14/2013.
Reacties
Er zijn nog geen reacties.